Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Jaro1977on Aug 10, 2020 10:00pm
203 Views
Post# 31390674

RE:RE:RE:RE:RE:RE:RE:RE:What a negative board now.....

RE:RE:RE:RE:RE:RE:RE:RE:What a negative board now.....Agree Quattro.

That TLD-1433 is being used in a study for nsclc at a leading cancer centre in the US is what reinforces why we are here for the potential greatness of Dr. Sherri's work.

Whenever I get down and frustrated by the stupidly low sp, recent bumble, fumble of the trial, I go re-read all the studies, peer reviews, other case use papers.

Remember, 2 people are (hopefully) still CR at over 2 years. 

People come in all shapes, sizes and baldders differ.  Were you ever the guy at the bar that had to piss 3-4 times more than your buddies?  The team made a mistake in how to calculate the amount of TLD, light and exposure for the various sized bladders and still, still seemed to have 4 at 100% CR at 90days!

This has been caught and should be rectified going forward.  Trials are performed to refine the process to prove the method, science.  That is what is happening
Bullboard Posts